An Act enabling trained school personnel to administer life saving epinephrine treatment
Take action
Record your position on this measure.
Create an account to take a stance, submit a written position, or contact your legislator.
Progress
Where this bill stands in the legislative process.
- Introduced
- Passed House
- Passed Senate
- To Governor
- Became Law
Overview
This bill allows trained school personnel, such as nurses and counselors, to administer epinephrine auto-injectors (like EpiPens) to students experiencing severe allergic reactions. It aims to improve student safety by ensuring quick access to life-saving medication when needed. The bill recognizes that rapid treatment can be crucial in emergency situations involving anaphylaxis. It builds upon previous attempts to establish this policy in Massachusetts.
Key provisions
- Allows trained school personnel to administer epinephrine.
- Specifies the types of training required for personnel to administer epinephrine.
- Requires schools to maintain an adequate supply of epinephrine auto-injectors.
- Mandates that epinephrine auto-injectors be readily accessible during school hours.
- Requires schools to develop and implement protocols for administering epinephrine.
- Addresses liability concerns for school personnel administering epinephrine.
- Requires schools to notify parents of the availability of epinephrine and the training of staff.
- Ensures proper storage and maintenance of epinephrine auto-injectors.
Who is affected
- Students
- School personnel (nurses, counselors, etc.)
- School administrators
- School districts
- Parents of students
Notable changes
Bill text
Read the latest version inline or switch to a previous version.
Text extraction is in progress. View the official source.
Sponsors
Official sponsors from legislative records.
3 on record
Primary sponsor
Cosponsors
Patrick Joseph Kearney
Arguments
Reasons offered for and against this legislation.
Arguments in favor
No arguments in favor have been submitted.
Submit yoursArguments opposed
No arguments opposed have been submitted.
Submit yours